San Francisco, California
London, United Kingdom
- Are you a Health & Life Sciences researcher wishing to meet people from different areas of expertise and find new career paths?
- Are you a budding entrepreneur looking to expand your team and meet you potential future team members?
- Are you a Tech & Science professional interested in forging new connections?
- Do you have an idea and want to discuss how to submit your application for BioStars 2017?
Come at one of our BioStars matchmaking events and take a step forward in your next venture!
This social networking event with Tech/Health & Life Sciences professionals and researchers is brought to you by Panacea Innovation, to encourage cross-collaborations as well as team-building in view of the upcoming BioStars 2017 intake!
What is BioStars?
BioStars is a life and health sciences comprehensive accelerator programme. If you are passionate about turning a scientific idea into a start-up business, this is your opportunity to take concrete steps.
Application deadline: Wed 7th December 2016, h2359 (BST).
How does BioStars work?
Open stream for those with an innovative life sciences idea, across all life and health science disciplines at any developmental stage.
Structured stream for those interested in novel pre-developed high impact projects with our industrial partners.
-£30 000 Non-dilutive funding
-INFRASTRUCTURE: Facilitated Lab and Office Space
-4D MENTORSHIP AND ONGOING SUPPORT: Scientific, Business Development, Legal/IP, Investment/VC
-WAIVING CROWDFUNDING LEGAL AND ADMINISTRATIVE FEES
...and A FEW MORE SURPRISES TO FOLLOW!
When & Where
Panacea Innovation (formerly Oxford Biotech) is an umbrella underneath which novel initiatives are introduced to mine for “undervalued assets” in the Academia/Industry/Investment triple-helix and give rise to high-impact assets, whenever and wherever.
Our mission is to change the way the world does science, for the betterment of humankind, by establishing vehicles that aim to maximize life and health sciences translation whilst providing outstanding revenues to our partners.
Panacea Innovation initiatives are broad ranging. From academia, where funding and credit for scientists and clinicians can be controlled by publishing lots of low- impact papers or speaking at conferences in a cycle that seems underperforming, to industry where the declining R&D productivity has raised doubts about the sustainability of its renowned financial returns, to venture capital where investors still need a better established deal flow rather than looking for the Nash equilibrium.